NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD
NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD
复制标题
DOI:
10.1038/tpj.2015.43
复制
发表时间:
2016-06-01
影响因子:
2.8
通讯作者:
Shimosegawa, T.
中科院分区:
文献类型:
--
作者:
Kakuta, Y.;Naito, T.;Shimosegawa, T.
The efficacy of thiopurines, including azathioprine (AZA) and 6-mercaptopurine (6MP), has been demonstrated for the treatment of inflammatory bowel disease (IBD). The most common and serious adverse event of treatment with thiopurines altered by doctors is leukopenia. Hair loss is also a serious event that could be a critical reason for patients to decline thiopurine treatment. Thiopurine-induced severe hair loss causes cosmetic problems, and it takes a long time to recover. In a recent study, NUDT15 R139C was strongly associated with thiopurine-induced leukopenia in Korean and Caucasian populations. In this study, we performed an association study to investigate and replicate the association of R139C with adverse events of thiopurines in Japanese patients. A total of 142 Japanese patients with IBD, with histories of thiopurine treatment, were examined. NUDT15 R139C was genotyped using a custom TaqMan genotyping assay. Adverse events including leukopenia were reviewed from medical records. The 6MP dose was adjusted to AZA equivalents by multiplying with 2 as a thiopurine dose. Five patients developed severe hair loss and all of them were risk homozygous (T/T) for R139C. No early severe hair loss was observed in patients with the C/T or C/C genotype (P = 3.82 x 10(-16), odds ratio = 212). The association of R139C with early (